ifosfamide has been researched along with Leukemia, Plasma Cell in 1 studies
Leukemia, Plasma Cell: A rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two patients with primary plasma cell leukemia (PLC) treated with a single agent, ifosfamide." | 2.38 | Ifosfamide in plasma cell leukemia: a report of two cases and review of the literature. ( Advani, SH; Dhabhar, BN; Gopal, R; Malhotra, H; Nadkarni, KS; Nair, CN; Saikia, TK, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malhotra, H | 1 |
| Dhabhar, BN | 1 |
| Saikia, TK | 1 |
| Gopal, R | 1 |
| Nadkarni, KS | 1 |
| Nair, CN | 1 |
| Advani, SH | 1 |
1 review available for ifosfamide and Leukemia, Plasma Cell
| Article | Year |
|---|---|
Ifosfamide in plasma cell leukemia: a report of two cases and review of the literature.
Topics: Adult; Female; Humans; Ifosfamide; Leukemia, Plasma Cell; Middle Aged | 1992 |